109 related articles for article (PubMed ID: 15878201)
21. Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.
McKenna SD; Feger G; Kelton C; Yang M; Ardissone V; Cirillo R; Vitte PA; Jiang X; Campbell RK
J Pharmacol Exp Ther; 2007 Aug; 322(2):822-8. PubMed ID: 17495128
[TBL] [Abstract][Full Text] [Related]
22. Construction of TNF-binding proteins by grafting hypervariable regions of F10 antibody on human fibronectin domain scaffold.
Petrovskaya LE; Shingarova LN; Kryukova EA; Boldyreva EF; Yakimov SA; Guryanova SV; Novoseletsky VN; Dolgikh DA; Kirpichnikov MP
Biochemistry (Mosc); 2012 Jan; 77(1):62-70. PubMed ID: 22339634
[TBL] [Abstract][Full Text] [Related]
23. Production of recombinant tumor necrosis factor receptor/Fc fusion protein by genetically manipulated chickens.
Kyogoku K; Yoshida K; Watanabe H; Yamashita T; Kawabe Y; Motono M; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2008 May; 105(5):454-9. PubMed ID: 18558334
[TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
[TBL] [Abstract][Full Text] [Related]
25. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
[TBL] [Abstract][Full Text] [Related]
26. Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.
Tsukamoto H; Fukudome K; Kohara J; Nakatake H; Kimoto M
Protein Expr Purif; 2007 Nov; 56(1):138-44. PubMed ID: 17703948
[TBL] [Abstract][Full Text] [Related]
27. An anti-human recombinant tumor necrosis factor alpha (TNF alpha) monoclonal antibody recognizes an epitope in feline TNF alpha.
Aguirre A; Escobar A; Ferreira V; Molina MC; Ferreira A; Aguillón JC
Vet Res; 2003; 34(2):177-84. PubMed ID: 12657209
[TBL] [Abstract][Full Text] [Related]
28. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
[TBL] [Abstract][Full Text] [Related]
29. Selection, design, and engineering of therapeutic antibodies.
Presta LG
J Allergy Clin Immunol; 2005 Oct; 116(4):731-6; quiz 737. PubMed ID: 16210043
[TBL] [Abstract][Full Text] [Related]
30. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
31. Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli.
Jia D; Yang H; Wan L; Cheng J; Lu X
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2345-55. PubMed ID: 22207214
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
[TBL] [Abstract][Full Text] [Related]
33. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
[TBL] [Abstract][Full Text] [Related]
34. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
36. [Biological characteristics and effect of TNF-alpha binding peptide and TNFR blocking peptide in vitro].
Yin BJ; Yu MX; Wang J; Jiang XD; Li ZY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):172-5. PubMed ID: 17286914
[TBL] [Abstract][Full Text] [Related]
37. Construction, expression, and characterization of a new targeted bifunctional fusion protein: tumstatin45-132-TNF.
Luo YQ; Wang LH; Ma XL; Kong JX; Jiao BH
IUBMB Life; 2006 Nov; 58(11):647-53. PubMed ID: 17085384
[TBL] [Abstract][Full Text] [Related]
38. Covalent dimerization of camelidae anti-human TNF-alpha single domain antibodies by the constant kappa light chain domain improves neutralizing activity.
Giersberg M; Floss DM; Kipriyanov S; Conrad U; Scheller J
Biotechnol Bioeng; 2010 May; 106(1):161-6. PubMed ID: 20047190
[TBL] [Abstract][Full Text] [Related]
39. [The role of PPARbeta in the apoptotic HaCaT keratinocytes induced by TNF-alpha].
Liang PF; Jiang BM; Zhang PH; Yang XH; Long JH; Huang XY
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2144-8. PubMed ID: 17988538
[TBL] [Abstract][Full Text] [Related]
40. Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling.
Zhang W; Feng J; Li Y; Guo N; Shen B
Mol Immunol; 2005 Aug; 42(12):1445-51. PubMed ID: 15950738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
